Thus, while inhibition of VEGFR2 decreases the number of lesions, it does not significantly affect the distribution of lesion size, suggesting that VEGF may be more important for the initiation, but not the growth, of CCM lesions. The gene discussed is VEGFA; the disease is cerebral cavernous malformation.